Regulation And Legal
Sun Pharma Receives Brazil Semaglutide Approval
Sun Pharma received ANVISA approval to manufacture and market semaglutide injection for type 2 diabetes in Brazil.
The company plans to launch the product in partnership with Hypera Pharma in two pre-
